Perbufylline
- Level
- Commodity
- Parent
- 51161500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51161551This classification denotes a phosphodiesterase inhibitor and bronchodilator, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M69H5TDQ1K. European Medicines Agency schedules Perbufylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09717MIG. Perbufylline generally arises in the molecular formula C23H28FN5O3. The term PERBUFYLLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, no. 3, 1988, list 28.) PERBUFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule perbufylline under HS 29395900 and SITC 54145. As of Q4 2014, PERBUFYLLINE remains the US FDA Preferred Term for this commodity. Perbufylline bears US NLM identifiers UMLS ID C1882325 and NCI Concept Code C66354. SMILES: FC1CCC(C(=O)C2CCN(CC2)CCCCN2C3C(N(C(=O)N(C3=O)C)C)NC2)CC1.
Same parent
Under 51161500 · 56Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.